Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT01164163
Title	INCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative Disease
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	Children's Oncology Group\|National Cancer Institute (NCI)
Indications	myelodysplastic/myeloproliferative neoplasm childhood leukemia Advanced Solid Tumor
Therapies	Ruxolitinib
Age Groups:	child
Covered Countries	USA